Citations (225)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kirsten L. Wahlstrøm, Sarah Ekeloef, Ismail Gögenur & Anna-Marie B. Münster. (2023) Myocardial injury after non-cardiac surgery and per operative fibrin metabolism in patients undergoing hip-fracture surgery: an observational study. Scandinavian Journal of Clinical and Laboratory Investigation 83:5, pages 299-308.
Read now
Read now
Naif M. Alhawiti & Sultan A. Alqahtani. (2019) Chronic testosterone administration improves cardiac contractility and has a beneficial effect on the haemostatic system by enhancing fibrinolytic activity and inducing hypocoagulation in healthy rats. Archives of Physiology and Biochemistry 125:4, pages 311-320.
Read now
Read now
Betül Usluoğullari, Ikbal Kaygusuz, Serap Simavli, Ayla Eser & İknur Inegol Gumus. (2015) Effects of cesarean section on mean platelet volume. Platelets 26:7, pages 657-660.
Read now
Read now
Yohei Yukizawa, Yutaka Inaba, Naomi Kobayashi, Hiroyuki Ike, So Kubota & Tomoyuki Saito. (2014) Selective pharmacological prophylaxis based on individual risk assessment using plasma levels of soluble fibrin and plasminogen-activator inhibitor-1 following total hip arthroplasty. Modern Rheumatology 24:5, pages 835-839.
Read now
Read now
Sabina Halappanavar, Martin R. Stampfli, Lynn Berndt-Weis, Andrew Williams, George R. Douglas & Carole L. Yauk. (2009) Toxicogenomic Analysis of Mainstream Tobacco Smoke-Exposed Mice Reveals Repression of Plasminogen Activator Inhibitor-1 Gene in Heart. Inhalation Toxicology 21:1, pages 78-85.
Read now
Read now
M. Szczepański, J. Kubiak & L. Lembas. (1998) Postoperative Injection of Phenylbutazone Does not Influence Fibrinolytic Shutdown. Current Medical Research and Opinion 14:2, pages 105-110.
Read now
Read now
F. Samad, G. Bergtrom, P. I. Lelkes, V. Rajappa & D. L. Amrani. (1995) Differential Cytokine Regulation of PAI-1 Gene Expression Between Human Umbilical and Subcutaneous Fat-Derived Microvascular Endothelial Cells. Endothelium 3:3, pages 243-252.
Read now
Read now
L. Buø, T. S. Karlsrud, H. T. Johansen & A. O. Aasen. (1993) The contact system in human malignant and benign ascites. Scandinavian Journal of Clinical and Laboratory Investigation 53:2, pages 117-124.
Read now
Read now
Felicita Andreotti & Cornelis Kluft. (1991) Circadian Variation of Fibrinolytic Activity in Blood. Chronobiology International 8:5, pages 336-351.
Read now
Read now
Bengt I. Eriksson, Elsa Eriksson, Erika Gyzander, Ann-Catrine Teger-nilsson & Bo Risberg. (1989) Thrombosis after hip replacement: Relationship to the fibrinolytic system. Acta Orthopaedica Scandinavica 60:2, pages 159-163.
Read now
Read now
Articles from other publishers (215)
Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, James Chandler & Angela Sauaia. (2023) Combination of aspirin and rosuvastatin for reduction of venous thromboembolism in severely injured patients: a double-blind, placebo-controlled, pragmatic randomized phase II clinical trial (The STAT Trial). Blood Coagulation & Fibrinolysis 34:8, pages 499-507.
Crossref
Crossref
Lucy A. Coupland, David J. Rabbolini, Jonathan G. Schoenecker, Philip J. Crispin, Jennene J. Miller, Tony Ghent, Robert L. Medcalf & Anders E. Aneman. (2023) Point-of-care diagnosis and monitoring of fibrinolysis resistance in the critically ill: results from a feasibility study. Critical Care 27:1.
Crossref
Crossref
Gordon Ogweno & Edwin Kimathi Murungi. 2023. Advances in the Diagnosis and Management of Vascular Thrombosis [Working Title]. Advances in the Diagnosis and Management of Vascular Thrombosis [Working Title].
Hui Zhu, Chaohua Lan, Dong Zhao, Ning Wang, Di Du, Huibo Luo, Huiqiang Lu, Zhifu Peng, Yumeng Wang, Zongwei Qiao, Yong Huang & Baoguo Sun. (2022) Wuliangye Baijiu but not ethanol reduces cardiovascular disease risks in a zebrafish thrombosis model. npj Science of Food 6:1.
Crossref
Crossref
M. Margaret Knudson, Hunter B. Moore, Ernest E. Moore, Lucy Z. Kornblith, Lazlo N. Kiraly, Michelle K. McNutt, Charles E. Wade, Brandon R. Bruns & Angela Sauaia. (2022) Tissue plasminogen activator resistance is an early predictor of posttraumatic venous thromboembolism: A prospective study from the CLOTT research group. Journal of Trauma and Acute Care Surgery 93:5, pages 597-603.
Crossref
Crossref
Hunter B. Moore. (2022) Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States. Seminars in Thrombosis and Hemostasis.
Crossref
Crossref
Peifeng Huang, Qingwei Zuo, Yue Li, Patrick Kwabena Oduro, Fengxian Tan, Yuanyuan Wang, Xiaohui Liu, Jing Li, Qilong Wang, Fei Guo, Yue Li & Long Yang. (2022) A Vicious Cycle: In Severe and Critically Ill COVID-19 Patients. Frontiers in Immunology 13.
Crossref
Crossref
Weng-Kit Sou, Cherng-Kang Perng, Hsu Ma & Yu-Chung Shih. (2022) Perioperative Myocardial Infarction in Free Flap for Head and Neck Reconstruction. Annals of Plastic Surgery 88:1s, pages S56-S61.
Crossref
Crossref
Kirsten L. Wahlstrøm, Sarah Ekeloef, Johannes J. Sidelmann, Ismail Gögenur & Anna-Marie B. Münster. (2022) Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial. Blood Coagulation & Fibrinolysis 33:1, pages 25-33.
Crossref
Crossref
Paul T. Williams. (2021) Quantile‐specific heritability of plasminogen activator inhibitor type‐1 (PAI‐1, aka SERPINE1) and other hemostatic factors. Journal of Thrombosis and Haemostasis 19:10, pages 2559-2571.
Crossref
Crossref
Navin G. Vigneshwar, Hunter B. Moore & Ernest E. Moore. (2021) Trauma-Induced Coagulopathy: Diagnosis and Management in 2020. Current Anesthesiology Reports 11:3, pages 363-372.
Crossref
Crossref
Justin E. Richards, Benjamin T. Fedeles, Jonathan H. Chow, Jonathan J. Morrison, Corinne Renner, Anthony T. Trinh, Caroline S. Schlee, Ken Koerner, Thomas E. Grissom, Richard D. Betzold, Thomas M. Scalea & Rosemary A. Kozar. (2021) Is Tranexamic Acid Associated With Mortality or Multiple Organ Failure Following Severe Injury?. Shock 55:1, pages 55-60.
Crossref
Crossref
Gregory R. Stettler, Ernest E. Moore & Hunter B. Moore. 2021. Trauma Induced Coagulopathy. Trauma Induced Coagulopathy
535
546
.
Akbar Dorgalaleh, Mehran Bahraini & Sayed Esmaeil Ahmadi. 2021. Personalized Medicine in Anesthesia, Pain and Perioperative Medicine. Personalized Medicine in Anesthesia, Pain and Perioperative Medicine
231
274
.
Dong Wang, Yongshuai Yang, Yu Wang, Valérie Proulle, Peter A. Andreasen, Wanjin Hong, Zhuo Chen, Mingdong Huang & Peng Xu. (2020) Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis. Biomedicine & Pharmacotherapy 130, pages 110528.
Crossref
Crossref
Marli Smit, A.R. Coetzee & A. Lochner. (2020) The Pathophysiology of Myocardial Ischemia and Perioperative Myocardial Infarction. Journal of Cardiothoracic and Vascular Anesthesia 34:9, pages 2501-2512.
Crossref
Crossref
Haili Lin, Luning Xu, Shujuan Yu, Wanjin Hong, Mingdong Huang & Peng Xu. (2020) Therapeutics targeting the fibrinolytic system. Experimental & Molecular Medicine 52:3, pages 367-379.
Crossref
Crossref
Sana Idrees, Jayanth Sridhar & Ajay E. Kuriyan. (2020) Perioperative Management of Antiplatelet Therapy in Ophthalmic Surgery. International Ophthalmology Clinics 60:3, pages 17-30.
Crossref
Crossref
Xin Xu & Xu Cao. 2020. Principles of Bone Biology. Principles of Bone Biology
1153
1187
.
Hunter B. Moore, Ernest E. Moore, Matthew D. Neal, Forest R. Sheppard, Lucy Z. Kornblith, Dominik F. Draxler, Mark Walsh, Robert L. Medcalf, Mitch J. Cohen, Bryan A. Cotton, Scott G. Thomas, Christine M. Leeper, Barbara A. Gaines & Angela Sauaia. (2019) Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications. Anesthesia & Analgesia 129:3, pages 762-773.
Crossref
Crossref
Yehuda Raveh, Fouad Souki, Joshua Livingstone, Thiago Beduschi, Rodrigo Vianna, Yiliam Rodriguez & Ramona Nicolau-Raducu. (2019) Fibrinolytic Shutdown Is Associated With Intraoperative Thrombosis and Hemorrhage During Visceral Transplant. Seminars in Cardiothoracic and Vascular Anesthesia 23:3, pages 300-308.
Crossref
Crossref
Hunter B. Moore, Ernest E. Moore, Michael P. Chapman, Kirk C. Hansen, Mitchell J. Cohen, Frederic M. Pieracci, James Chandler & Angela Sauaia. (2019) Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?. Journal of the American College of Surgeons 229:1, pages 92-101.
Crossref
Crossref
Ramona Nicolau‐Raducu, Thiago Beduschi, Rodrigo Vianna, Christian Diez, Mahmoud Sleem, Bhavna P. Singh, Georgia Vasileiou & Yehuda Raveh. (2019) Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation. Liver Transplantation 25:3, pages 380-387.
Crossref
Crossref
Laura C. Burlage, Sarah Bos, Jelle Adelmeijer, Takumi Sakai, Robert J. Porte & Ton Lisman. (2019) Plasma From Patients Undergoing Liver Transplantation Is Resistant to Anticoagulant Activity of Soluble Thrombomodulin. Liver Transplantation 25:2, pages 252-259.
Crossref
Crossref
Janice W. Lawson & Craig S. Kitchens. 2019. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
696
720
.
Jerrold H. Levy, Andreas Koster, Quintin J. Quinones, Truman J. Milling & Nigel S. Key. (2018) Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology 128:3, pages 657-670.
Crossref
Crossref
Julien Lanoiselée, Paul J. Zufferey, Edouard Ollier, Sophie Hodin & Xavier Delavenne. (2018) Is tranexamic acid exposure related to blood loss in hip arthroplasty? A pharmacokinetic-pharmacodynamic study. British Journal of Clinical Pharmacology 84:2, pages 310-319.
Crossref
Crossref
Xin Xu, Liwei Zheng, Quan Yuan, Gehua Zhen, Janet L. Crane, Xuedong Zhou & Xu Cao. (2018) Transforming growth factor-β in stem cells and tissue homeostasis. Bone Research 6:1.
Crossref
Crossref
Paul J. Zufferey, Julien Lanoiselée, Céline Chapelle, Dmitry B. Borisov, Jean-Yves Bien, Pierre Lambert, Rémi Philippot, Serge Molliex & Xavier Delavenne. (2017) Intravenous Tranexamic Acid Bolus plus Infusion Is Not More Effective than a Single Bolus in Primary Hip Arthroplasty. Anesthesiology 127:3, pages 413-422.
Crossref
Crossref
Atsushi Kimura, Tsukasa Ohmori, Asuka Sakata, Teruaki Endo, Hirokazu Inoue, Satoshi Nishimura & Katsushi Takeshita. (2017) Hemostatic function to regulate perioperative bleeding in patients undergoing spinal surgery: A prospective observational study. PLOS ONE 12:6, pages e0179829.
Crossref
Crossref
Karin E. Mossberg, Dimitri J. Pournaras, Richard Welbourn, Carel W. le Roux & Helén Brogren. (2017) Differential response of plasma plasminogen activator inhibitor 1 after weight loss surgery in patients with or without type 2 diabetes. Surgery for Obesity and Related Diseases 13:1, pages 53-57.
Crossref
Crossref
P Pinsornsak, S Rojanavijitkul & S Chumchuen. (2016) Peri-articular tranexamic acid injection in total knee arthroplasty: a randomized controlled trial. BMC Musculoskeletal Disorders 17:1.
Crossref
Crossref
M. Maegele. (2016) Unkritischer Gebrauch von Tranexamsäure bei TraumapatientenUncritical use of tranexamic acid in trauma patients. Der Unfallchirurg 119:11, pages 967-972.
Crossref
Crossref
Simone F. Kleiss, Jelle Adelmeijer, Joost C.M. Meijers, Robert J. Porte & Ton Lisman. (2016) A sustained decrease in plasma fibrinolytic potential following partial liver resection or pancreas resection. Thrombosis Research 140, pages 36-40.
Crossref
Crossref
Takuya Shimizu, Manabu Uematsu, Toru Yoshizaki, Jun-ei Obata, Takamitsu Nakamura, Daisuke Fujioka, Kazuhiro Watanabe, Yosuke Watanabe & Kiyotaka Kugiyama. (2016) Myocardial Production of Plasminogen Activator Inhibitor-1 is Associated with Coronary Endothelial and Ventricular Dysfunction after Acute Myocardial Infarction. Journal of Atherosclerosis and Thrombosis 23:5, pages 557-566.
Crossref
Crossref
AtulP Kulkarni, DevendraA Chaukar, VijayaP Patil, RajendraB Metgudmath, RohiniW Hawaldar & JigeeshuV Divatia. (2016) Does tranexamic acid reduce blood loss during head and neck cancer surgery?. Indian Journal of Anaesthesia 60:1, pages 19.
Crossref
Crossref
Han Chen, Huan Peng, Wenwu Liu, Yanping Sun, Ning Su, Wentao Tang, Xiaoli Zhang, Jian Wang, Long Cui, Pingfang Hu & Sheng Liu. (2015) Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis. Surgery 158:6, pages 1704-1713.
Crossref
Crossref
Lilian Tengborn, Margareta Blombäck & Erik Berntorp. (2015) Tranexamic acid – an old drug still going strong and making a revival. Thrombosis Research 135:2, pages 231-242.
Crossref
Crossref
Douglas B. Kell & Etheresia Pretorius. (2015) The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). Integrative Biology 7:1, pages 24-52.
Crossref
Crossref
Hunter B. Moore, Ernest E. Moore, Eduardo Gonzalez, Michael P. Chapman, Theresa L. Chin, Christopher C. Silliman, Anirban Banerjee & Angela Sauaia. (2014) Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown. Journal of Trauma and Acute Care Surgery 77:6, pages 811-817.
Crossref
Crossref
Pål O. Borgen, Ola E. Dahl & Olav Reikeras. (2013) Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis. Thrombosis 2013, pages 1-6.
Crossref
Crossref
Taki Galanis & Geno J. Merli. 2013. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
234
251
.
Judith A.R. van WaesHendrik M. NathoeJurgen C. de GraaffHans KempermanGert Jan de BorstLinda M. PeelenWilton A. van KleiWolfgang F. Buhre, Jurgen C. de Graaff, Cor J. Kalkman, Wilton A. van Klei, Judith A.R. van Waes, Leo van Wolfswinkel, Pieter A. Doevendans, Hendrik M. Nathoe, Remco G. Grobben, Diederik E. Grobbee, Linda M. Peelen, Hans Kemperman, Wouter W. van Solinge, Tim Leiner, Gert Jan de Borst, Loek P.H. Leenen & Frans L. Moll. (2013) Myocardial Injury After Noncardiac Surgery and its Association With Short-Term Mortality. Circulation 127:23, pages 2264-2271.
Crossref
Crossref
Craig S. Kitchens & Janice W. Lawson. 2013. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
651
672
.
Taki Galanis & Geno J. Merli. 2013. Perioperative Management of Patients with Rheumatic Disease. Perioperative Management of Patients with Rheumatic Disease
45
56
.
Eric G. Butchart & Raffaele De Caterina. 2012. Therapeutic Advances in Thrombosis. Therapeutic Advances in Thrombosis
246
271
.
Elisabeth E Husebye, Torstein Lyberg, Helge Opdahl, Trude Aspelin, Ragnhild Ø Støen, Jan Erik Madsen & Olav Røise. (2012) Intramedullary nailing of femoral shaft fractures in polytraumatized patients. a longitudinal, prospective and observational study of the procedure-related impact on cardiopulmonary- and inflammatory responses. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 20:1, pages 2.
Crossref
Crossref
Taki Galanis, Walter K. Kraft & Geno J. Merli. (2011) Prophylaxis for Deep Vein Thrombosis and Pulmonary Embolism in the Surgical Patient. Advances in Surgery 45:1, pages 361-390.
Crossref
Crossref
Elisabeth Ellingsen Husebye, Helge Opdahl, Olav Røise, Trude Aspelin & Torstein Lyberg. (2011) Coagulation, fibrinolysis and cytokine responses to intramedullary nailing of the femur: An experimental study in pigs comparing traditional reaming and reaming with a one-step reamer-irrigator-aspirator system. Injury 42:7, pages 630-637.
Crossref
Crossref
G. Y. H. Lip, O. M. Durrani, V. Roldan, P. L. Lip, F. Marin & T. Q. Reuser. (2011) Peri-operative management of ophthalmic patients taking antithrombotic therapy. International Journal of Clinical Practice 65:3, pages 361-371.
Crossref
Crossref
Ton Lisman & Robert J. Porte. 2011. Molecular Pathology of Liver Diseases. Molecular Pathology of Liver Diseases
701
708
.
Frank C. Vandy & Thomas W. Wakefield. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery
736
754
.
Olav Reikeras & Torkil Clementsen. (2009) Thrombosis Markers in Hip versus Knee Arthroplasty: A Pilot Study. Journal of Orthopaedic Surgery 17:3, pages 291-295.
Crossref
Crossref
R. Selby, W. Geerts, F.A. Ofosu, S. Craven, L. Dewar, A. Phillips & J.P. Szalai. (2009) Hypercoagulability after trauma: Hemostatic changes and relationship to venous thromboembolism. Thrombosis Research 124:3, pages 281-287.
Crossref
Crossref
Giora LandesbergW. Scott BeattieMorris MosseriAllan S. JaffeJoseph S. Alpert. (2009) Perioperative Myocardial Infarction. Circulation 119:22, pages 2936-2944.
Crossref
Crossref
Joris J.T.H. Roelofs, Gwendoline J.D. Teske, Peter I. Bonta, Carlie J.M. de Vries, Joost C.M. Meijers, Jan J. Weening, Tom van der Poll & Sandrine Florquin. (2009) Plasminogen activator inhibitor-1 regulates neutrophil influx during acute pyelonephritis. Kidney International 75:1, pages 52-59.
Crossref
Crossref
Jasimuddin Ahamed, Nathalie Burg, Keiji Yoshinaga, Christin A. Janczak, Daniel B. Rifkin & Barry S. Coller. (2008) In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-β1. Blood 112:9, pages 3650-3660.
Crossref
Crossref
Helén Brogren, Carina Sihlbom, Karin Wallmark, Malin Lönn, Johanna Deinum, Lena Karlsson & Sverker Jern. (2008) Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin. Thrombosis Research 122:2, pages 271-281.
Crossref
Crossref
Marlien Pieters & Hester H. Vorster. (2008) Nutrition and hemostasis: A focus on urbanization in South Africa. Molecular Nutrition & Food Research 52:1, pages 164-172.
Crossref
Crossref
Craig S. Kitchens. 2007. Consultative Hemostasis and Thrombosis. Consultative Hemostasis and Thrombosis
611
634
.
Geno J. Merli. 2010. Medical Management of the Surgical Patient. Medical Management of the Surgical Patient
248
268
.
Dirk Sibbing, Olga von Beckerath, Nicolas von Beckerath, Werner Koch, Julinda Mehilli, Markus Schwaiger, Albert Schömig & Adnan Kastrati. (2005) Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction. Blood Coagulation & Fibrinolysis 16:7, pages 511-515.
Crossref
Crossref
R. RENCKENS, J.J.T.H. ROELOFS, V. DE WAARD, S. FLORQUIN, H.R. LIJNEN, P. CARMELIET & T. VAN DER POLL. (2005) The role of plasminogen activator inhibitor type 1 in the inflammatory response to local tissue injury. Journal of Thrombosis and Haemostasis 3:5, pages 1018-1025.
Crossref
Crossref
Claudia Dellas & David J. Loskutoff. (2017) Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thrombosis and Haemostasis 93:04, pages 631-640.
Crossref
Crossref
Verena Pihusch, Markus Pihusch, Marius Penovici, Hans J. Kolb, Erhard Hiller & Rudolf Pihusch. (2005) Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thrombosis Research 116:3, pages 233-240.
Crossref
Crossref
E.M. Awad. (2005) In vitro decreases of the fibrinolytic potential of cultured human fibrosarcoma cell line, HT1080, by Nigella sativa oil. Phytomedicine 12:1-2, pages 100-107.
Crossref
Crossref
Kurtis I. Auguste, Alfredo Quiñones-Hinojosa & Mitchel S. Berger. (2004) Efficacy of mechanical prophylaxis for venous thromboembolism in patients with brain tumors. Neurosurgical Focus 17:4, pages 1-5.
Crossref
Crossref
Michael Lefevre, Penny M. Kris-Etherton, Guixiang Zhao & Russell P. Tracy. (2004) Dietary fatty acids, hemostasis, and cardiovascular disease risk11Continuing Education Questionnaire, page 492 Meets learning need codes 4040, 4050, 5160, and 9020. Journal of the American Dietetic Association 104:3, pages 410-419.
Crossref
Crossref
Nilesh H. Patel. (2004) Limitations of Medical/Surgical Management of DVT. Journal of Vascular and Interventional Radiology 15:2, pages P62-P70.
Crossref
Crossref
Yoshihide Miyata, Satoshi Tomiyama, Moritaka Nagayama, Akira Arakaki, Rikito Hokama & Hidemaro Higa. (2004) Effects of Drain Clamped Method with Tranexamic Acid in Reducing Blood Loss during Cementless Total Knee Arthroplasty. Orthopedics & Traumatology 53:1, pages 51-54.
Crossref
Crossref
Russell P. Tracy. 2003. International Textbook of Diabetes Mellitus. International Textbook of Diabetes Mellitus.
Russell P. Tracy. (2003) Thrombin, Inflammation, and Cardiovascular Disease. Chest 124:3, pages 49S-57S.
Crossref
Crossref
Sabine Brueckner, Ulrike Reinke, Angela Roth-Isigkeit, Sawas Eleftheriadis, Peter Schmucker & Hans-Joachim G Siemens. (2003) Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty. Journal of Clinical Anesthesia 15:6, pages 433-440.
Crossref
Crossref
Nilesh H. Patel. (2003) DVT—Incidence, Pathogenesis, Clinical Features and Current Systemic Therapy. Journal of Vascular and Interventional Radiology 14:2, pages P283-P291.
Crossref
Crossref
Maciej Szczepański, Przemyslaw Szostek, Wojciech Pypno & Andrzej Borówka. (2001) The Lack of Effect of a Prophylactic Dose of Enoxaparin on Thrombin Generation in Patients Subjected to Nephrectomy Because of Kidney Cancer. Thrombosis Research 104:6, pages 427-432.
Crossref
Crossref
Toshinori Noguchi, Masayuki Noguchi, Hiroshi Masubuchi, Taiichiro Seki & Toyohiko Ariga. (2001) IL-1β Down-Regulates Tissue-Type Plasminogen Activator by Up-Regulating Low-Density Lipoprotein Receptor-Related Protein in AML 12 Cells. Biochemical and Biophysical Research Communications 288:1, pages 42-48.
Crossref
Crossref
Russell P. Tracy. (2001) Is Visceral Adiposity the “Enemy Within”?. Arteriosclerosis, Thrombosis, and Vascular Biology 21:6, pages 881-883.
Crossref
Crossref
Claus Danckert Krohn, Olav Reikerås, Stin. (2001) Fibrinolytic Activity and Postoperative Salvaged Untreated Blood for Autologous Transfusion in Major Orthopaedic Surgery. The European Journal of Surgery 167:3, pages 168-172.
Crossref
Crossref
G. Malukiewicz-Wiśniewska & M. Kotschy. (2018) Fibrinolytic Response to Retinal Detachment Surgery under General or Local Anesthesia. European Journal of Ophthalmology 11:1, pages 66-72.
Crossref
Crossref
F. Bachmann. 2001. Fibrinolytics and Antifibrinolytics. Fibrinolytics and Antifibrinolytics
3
23
.
Gustav Ekbäck, Kjell Axelsson, Lars Ryttberg, Bror Edlund, Jill Kjellberg, Johan Weckström, Olle Carlsson & Ulf Schött. (2000) Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery. Anesthesia & Analgesia 91:5, pages 1124-1130.
Crossref
Crossref
Gustav Ekbäck, Kjell Axelsson, Lars Ryttberg, Bror Edlund, Jill Kjellberg, Johan Weckström, Olle Carlsson & Ulf Schött. (2000) Tranexamic Acid Reduces Blood Loss in Total Hip Replacement Surgery. Anesthesia & Analgesia 91:5, pages 1124-1130.
Crossref
Crossref
Mojca Božič, Mojca Stegnar, Isabella Fermo, Anka Ritonja, Polona Peternel, Janez Stare & Armando D'Angelo. (2000) Mild Hyperhomocysteinemia and Fibrinolytic Factors in Patients with History of Venous Thromboembolism. Thrombosis Research 100:4, pages 271-278.
Crossref
Crossref
Mitchell A. Cahan, Dinah J. Hanna, Lara A. Wiley, Dorothy K. Cox & Lois A. Killewich. (2000) External pneumatic compression and fibrinolysis in abdominal surgery. Journal of Vascular Surgery 32:3, pages 537-543.
Crossref
Crossref
Menelaos Karanikolas & Robert A. Swarm. (2000) CURRENT TRENDS IN PERIOPERATIVE PAIN MANAGEMENT. Anesthesiology Clinics of North America 18:3, pages 575-599.
Crossref
Crossref
Hans Jørgen Nielsen, Ib Jarle Christensen, Steen Sørensen, Flemming Moesgaard & Nils Brünner. (2000) Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. Annals of Surgical Oncology 7:8, pages 617-623.
Crossref
Crossref
Antonino Gullo, Giorgio Berlot & Giovanni Galimberti. 2000. Multiple Organ Failure. Multiple Organ Failure
641
650
.
Diane E. Wallis, Bruce E. LewisHarry L. MessmoreRoque PifarreJeanine M. Walenga. (2016) Inadequacy of Current Prevention Strategies for Heparin-Induced Thrombocytopenia. Clinical and Applied Thrombosis/Hemostasis 5:1_suppl, pages S16-S20.
Crossref
Crossref
Taiichiro Seki, Annette M. Healy, Daniel S. Fletcher, Toshinori NoguchiThomas D. Gelehrter. (1999) IL-1β mediates induction of hepatic type 1 plasminogen activator inhibitor in response to local tissue injury. American Journal of Physiology-Gastrointestinal and Liver Physiology 277:4, pages G801-G809.
Crossref
Crossref
Russell P. Tracy. (1999) Inflammation markers and coronary heart disease. Current Opinion in Lipidology 10:5, pages 435-442.
Crossref
Crossref
Russell P. Tracy. (1999) Diet and hemostatic factors. Current Atherosclerosis Reports 1:3, pages 243-248.
Crossref
Crossref
Trevor Sutton & Peter Rock. (1999) Pro: β-blockers should be used in all patients undergoing vascular surgery. Journal of Cardiothoracic and Vascular Anesthesia 13:4, pages 490-495.
Crossref
Crossref
Geno J. Merli. (1999) DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM PROPHYLAXIS IN JOINT REPLACEMENT SURGERY. Rheumatic Disease Clinics of North America 25:3, pages 639-656.
Crossref
Crossref
R. Otero Candelera, M. Arenas Gordillo, J.E. Hurtado Ayuso, R. Moralesa, M. Monederoa & J. Digona. (1999) Búsqueda de marcadores clínicos de hipercoagulabilidad patológica según los factores desencadenantes de enfermedad tromboembólica venosa (ETV). Archivos de Bronconeumología 35:7, pages 329-333.
Crossref
Crossref
A. Holmberg, B. Westman, D. Berggvist & A. Siegbahn. (1999) Fibrinolysis in open abdominal aortic aneurysm surgery. Fibrinolysis and Proteolysis 13:4-5, pages 155-162.
Crossref
Crossref
Diane E Wallis, Diane L Workman, Bruce E Lewis, Lowell Steen, Roque Pifarre & John F Moran. (1999) Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. The American Journal of Medicine 106:6, pages 629-635.
Crossref
Crossref
M. Szczepański, W. Kucharski, J. Ratajczak & A.J. Meissner. (1999) Perioperative fibronolytic activity in cholecystectomized patients The postoperative fibrinolytic shutdown is only a temporary event. Fibrinolysis and Proteolysis 13:3, pages 118-123.
Crossref
Crossref
Hans B. Rahr, Knud Fabrin, Jens F. Larsen & Ole Thorlacius-Ussing. (1999) Coagulation and Fibrinolysis during Laparoscopic Cholecystectomy. Thrombosis Research 93:3, pages 121-127.
Crossref
Crossref
V. Ravi, K.G. Bergtrom & L.D. Amrani. (1998) Tyrosine kinase mediated regulation of PAI-1 production in HEL299 fibroblasts and HepG2 hepatoma cells. Fibrinolysis and Proteolysis 12:3, pages 165-172.
Crossref
Crossref
Brian A. Rosenfeld, Ngoc-Diep Nguyen, Ik Sung & Nauder Faraday. (1998) Neuroendocrine Stress Hormones Do Not Recreate the Postoperative Hypercoagulable State. Anesthesia & Analgesia 86:3, pages 640-645.
Crossref
Crossref
Brian A. Rosenfeld, Ngoc-Diep Nguyen, Ik Sung & Nauder Faraday. (1998) Neuroendocrine Stress Hormones Do Not Recreate the Postoperative Hypercoagulable State. Anesthesia & Analgesia 86:3, pages 640-645.
Crossref
Crossref
Vincent DeQuattro & Deping Li. (2016) Antihypertensive Therapy in Patients Undergoing Noncardiac Surgery. Journal of Cardiovascular Pharmacology and Therapeutics 2:4, pages 331-335.
Crossref
Crossref
H. SEEMAN-LODDING, S. HAGGMARK, C. JERN, S. TERN, G. JOHANSSON, O. WINSO & B. BIBER. (1997) Aortic cross-clamping influences regional net release and uptake rates of tissue-type plasminogen activator in pigs. Acta Anaesthesiologica Scandinavica 41:9, pages 1114-1123.
Crossref
Crossref
Franca CitarellaAngelina FeliciMieke BrouwerJohn WagstaffAntonio FantoniC. Erik Hack. (1997) Interleukin-6 Downregulates Factor XII Production by Human Hepatoma Cell Line (HepG2). Blood 90:4, pages 1501-1507.
Crossref
Crossref
Franca CitarellaAngelina FeliciMieke BrouwerJohn WagstaffAntonio FantoniC. Erik Hack. (1997) Interleukin-6 Downregulates Factor XII Production by Human Hepatoma Cell Line (HepG2). Blood 90:4, pages 1501-1507.
Crossref
Crossref
W. Pickering, M. Brozovic, M. Dancy & H. Cohen. (2016) Thrombolysis, With or Without Heparin, During the First Nine Weeks After Acute Myocardiat Infarction. Clinical and Applied Thrombosis/Hemostasis 3:3, pages 183-189.
Crossref
Crossref
Clive Kearon & Jack Hirsh. (1997) Management of Anticoagulation before and after Elective Surgery. New England Journal of Medicine 336:21, pages 1506-1511.
Crossref
Crossref
Lois A. Killewich, Richard F. Macko, Andrew W. Gardner, Kim Cox, Michael P. Lilly & William R. Flinn. (1997) Defective fibrinolysis occurs after infrainguinal reconstruction. Journal of Vascular Surgery 25:5, pages 858-865.
Crossref
Crossref
James M. Moore & Spencer S. Liu. (1997) How acute pain management affects outcome. Techniques in Regional Anesthesia and Pain Management 1:2, pages 64-71.
Crossref
Crossref
Göran Benoni, Stefan Lethagen & Hans Fredin. (1997) THE EFFECT OF TRANEXAMIC ACID ON LOCAL AND PLASMA FIBRINOLYSIS DURING TOTAL KNEE ARTHROPLASTY. Thrombosis Research 85:3, pages 195-206.
Crossref
Crossref
L. Veronica Lee, Dana R. Abendschein & Paul R. Eisenberg. 1997. Textbook of Coronary Thrombosis and Thrombolysis. Textbook of Coronary Thrombosis and Thrombolysis
421
447
.
Kim A. Eagle & James B. Froehlich. (1996) Reducing Cardiovascular Risk in Patients Undergoing Noncardiac Surgery. New England Journal of Medicine 335:23, pages 1761-1763.
Crossref
Crossref
Peter G. Atanassoff. (1996) Effects of regional anesthesia on perioperative outcome. Journal of Clinical Anesthesia 8:6, pages 446-455.
Crossref
Crossref
Taiichiro Seki & Thomas D. Gelehrter. (1996) Interleukin-1 induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression in the mouse hepatocyte line, AML 12. Journal of Cellular Physiology 168:3, pages 648-656.
Crossref
Crossref
Uri Martinowitz, Sam Schulman, Henri Horoszowski & Michael Heim. (1996) Role of Fibrin Sealants in Surgical Procedures on Patients With Hemostatic Disorders. Clinical Orthopaedics and Related Research 328, pages 65-75.
Crossref
Crossref
David G. Jacobs, Joseph J. Piotrowski, Debra A. Hoppensteadt, Ann E. Salvator & Jawed Fareed. (1996) Hemodynamic and Fibrinolytic Consequences of Intermittent Pneumatic Compression. The Journal of Trauma: Injury, Infection, and Critical Care 40:5, pages 710-717.
Crossref
Crossref
I. Juhan-Vague & M.C. Alessi. (1996) Fibrinolysis and risk of coronary artery disease. Fibrinolysis 10:3, pages 127-136.
Crossref
Crossref
Bruce D. Spiess. (1996) TRAUMATIC COAGULOPATHIES. Anesthesiology Clinics of North America 14:1, pages 29-38.
Crossref
Crossref
Irene M. Lang & Raymond R. Schleef. (1996) Calcium-dependent Stabilization of Type I Plasminogen Activator Inhibitor within Plateletα-Granules. Journal of Biological Chemistry 271:5, pages 2754-2761.
Crossref
Crossref
Bruce D. Spiess. 1996. Anesthesiology and the Cardiovascular Patient. Anesthesiology and the Cardiovascular Patient
111
121
.
Felicita Andreotti & Alessandro Manzoli. 1996. Triggering of Acute Coronary Syndromes. Triggering of Acute Coronary Syndromes
185
199
.
H. D. Bruhn & K.-H. Zurborn. 1996. Malignome und Hämostase. Malignome und Hämostase
3
15
.
Satoshi Gando, Yoshimi Nakanishi & Ichiro Tedo. (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation. Critical Care Medicine 23:11, pages 1835-1842.
Crossref
Crossref
M. Szczepański, T. Duchiński & P. Kretowicz. (1995) Single dose of nandrolone does not prevent postoperative fibrinolytic shutdown. Fibrinolysis 9:6, pages 350-355.
Crossref
Crossref
Osamu Hirashima, Hisao Ogawa, Shuichi Oshima, Tomohiro Sakamoto, Yoshio Honda, Shinji Sakata, Takenobu Masuda, Yuji Miyao & Hirofumi Yasue. (1995) Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: Difference between thrombolytic therapy and direct coronary angioplasty. American Heart Journal 130:5, pages 933-939.
Crossref
Crossref
Stephen C.L. Koh, H.L. Pua, Dicky H.B. Tay & S.S. Ratnam. (1995) The effects of gynaecological surgery on coagulation activation, fibrinolysis and fibrinolytic inhibitor in patients with and without ketorolac infusion. Thrombosis Research 79:5-6, pages 501-514.
Crossref
Crossref
Lene H. Iversen, Ole Thorlacius-Ussing & Mette Okholm. (1995) Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease. Thrombosis Research 79:5-6, pages 471-481.
Crossref
Crossref
Irene Juhan-Vague, Marie-Christine Alessi & Paul J. Declerck. (1995) 4 Pathophysiology of fibrinolysis. Baillière's Clinical Haematology 8:2, pages 329-343.
Crossref
Crossref
JJ Emeis. (2016) The Control of tPA and PAI-1 Secretion from the Vessel Wall. Vascular Medicine Review vmr-6:2, pages 153-166.
Crossref
Crossref
Chrysann Collatos, Michelle H. Barton & James N. Moore. (2008) Fibrinolytic Activity in Plasma From Horses With Gastrointestinal Diseases: Changes Associated With Diagnosis, Surgery, and Outcome. Journal of Veterinary Internal Medicine 9:1, pages 18-23.
Crossref
Crossref
A.J. Thornton & T.D. Gelehrter. (1995) Human hepatocytes express the gene for type 1 plasminogen activator-inhibitor (PAI-1) in vivo. Fibrinolysis 9:1, pages 9-15.
Crossref
Crossref
Jan Brunkwall, David Bergqvist, Lars-Olof Almér & Inga Marie Nilsson. (1995) Tissue plasminogen activator, its fast acting plasma inhibitor and protein C after renal transplantation. Thrombosis Research 77:1, pages 105-111.
Crossref
Crossref
Katsunori Aoki, Nobuhiko Nishino, Shozo Baba, Tetsumei Urano & Akikazu Takada. (1994) Postoperative changes in plasma tissue-type plasminogen activator and type I plasminogen activator inhibitor. Surgery Today 24:12, pages 1039-1043.
Crossref
Crossref
G. Vander Velpen, F. Penninckx, R. Kerremans, J. Van Damme & J. Arnout. (1994) Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy. Surgical Endoscopy 8:10, pages 1216-1220.
Crossref
Crossref
R. Kätzel, B. Wiedemann, H. Keuper & L. Brethner. (1994) The effect of the anaesthesia procedure on intraoperative fibrinolysis activation and postoperative fibrinolytic shut-down. Fibrinolysis 8:5, pages 309-316.
Crossref
Crossref
Mitsuo Shimada, Takashi Matsumata, Kazuharu Yamamoto, Hidetoshi Itasaka, Akinobu Taketomi & Keizo Sugimachi. (1994) Initiation of a fibrinolytic system in hepatic resection: The roles of tissue-type plasminogen activator and plasminogen activator inhibitor-1. Surgery Today 24:9, pages 780-784.
Crossref
Crossref
A.M. Healy & T.D. Gelehrter. (1994) Induction of plasminogen activator inhibitor-1 in HepG2 human hepatoma cells by mediators of the acute phase response.. Journal of Biological Chemistry 269:29, pages 19095-19100.
Crossref
Crossref
J. Schneiderman, R. Adar & M. Sawdey. (1994) Chronic glucocorticosteroid administration modulates the response of the fibrinolytic system to bacterial lipopolysaccharide. Fibrinolysis 8:4, pages 238-244.
Crossref
Crossref
F. Samad, G. Bergtrom & D.L. Amrani. (1994) Regulation of plasminogen activation by interleukin-6 in human lung fibroblasts. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1221:3, pages 307-314.
Crossref
Crossref
Jacob Schneiderman, Yutaka Eguchi, Raphael Adar & Michael Sawdey. (1994) Modulation of the fibrinolytic system by major peripheral ischemia. Journal of Vascular Surgery 19:3, pages 516-524.
Crossref
Crossref
Ikuo Misumi, Hisao Ogawa, Takenobu Masuda, Tomohiro Sakamoto, Ken Okumura & Hirofumi Yasue. (1993) Increased plasma plasminogen activator inhibitor activity after coronary spasm. International Journal of Cardiology 41:1, pages 21-29.
Crossref
Crossref
Ola E. Dahl, Trude Pedersen, Peter Kierulf, Åse-Britt Westvik, Per Lund, Harald Arnesen, Ingebjørg Seljeflot, Michael Abdelnoor & Torstein Lyberg. (1993) Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thrombosis Research 70:6, pages 451-458.
Crossref
Crossref
Geno J. Merli. (1993) Update: Deep vein thrombosis and pulmonary embolism prophylaxis in orthopedic surgery. Medical Clinics of North America 77:2, pages 397-411.
Crossref
Crossref
A. O. Aasen & L. Buø. 1993. Pathophysiology of Shock, Sepsis, and Organ Failure. Pathophysiology of Shock, Sepsis, and Organ Failure
36
45
.
M A OlmanJ J MarshI M LangK M MoserB R BinderR R Schleef. (1992) Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.. Circulation 86:4, pages 1241-1248.
Crossref
Crossref
K.J. Hofmann, E.J. Mayer, L.D. Schultz, S.H. Socher & C.F. Reilly. (1992) Purification and characterisation of recombinant rabbit plasminogen activator inhibitor-1 expressed in Saccharomyces cerevisiae. Fibrinolysis 6:4, pages 263-272.
Crossref
Crossref
Grazyna Rydzewska, Slawomir Kosidlo, Antoni Gabryelewicz & Andrzej Rydzewski. (1992) Tissue plasminogen activator, plasminogen activator inhibitor, and other parameters of fibrinolysis in the early stages of taurocholate acute pancreatitis in rats. International journal of pancreatology 11:3, pages 161-168.
Crossref
Crossref
A. Uddhammar, S. Rantapåå-Dahlqvist & T. K. Nilsson. (1992) Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica. Clinical Rheumatology 11:2, pages 211-215.
Crossref
Crossref
P M RidkerD E VaughanM J StampferJ E MansonC ShenL M NewcomerS Z GoldhaberC H Hennekens. (1992) Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.. Circulation 85:5, pages 1822-1827.
Crossref
Crossref
F. Haverkate. (1992) Low-grade acute-phase reactions in arteriosclerosis and the consequences for haemostatic risk factors. Fibrinolysis 6, pages 17-18.
Crossref
Crossref
Gere S. diZerega & Kathleen E. RodgersGere S. diZerega & Kathleen E. Rodgers. 1992. The Peritoneum. The Peritoneum
231
273
.
T. Harbourne, D. O'Brien & A.N. Nicolaides. (1991) Fibrinolytic activity in patients with idiopathic and secondary deep venous thrombosis. Thrombosis Research 64:5, pages 543-550.
Crossref
Crossref
Satoshi Fujii, Dana R. Abendschein & Burton E. Sobel. (1991) Augmentation of plasminogen activator inhibitor type 1 activity in plasma by thrombosis and by thrombolysis. Journal of the American College of Cardiology 18:6, pages 1547-1554.
Crossref
Crossref
L.J. Garcia Frade, L. Landin, A. Garcia Avello, J.A. Lorente & M.C. Torrado. (1991) PAI and D-D dimer levels are related to severity of injury in trauma patients. Fibrinolysis 5:4, pages 253-256.
Crossref
Crossref
D.J. Loskutoff. (1991) Regulation of PAI-1 gene expression. Fibrinolysis 5:4, pages 197-206.
Crossref
Crossref
C F ReillyT FujitaE J MayerM E Siegfried. (1991) Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.. Arteriosclerosis and Thrombosis: A Journal of Vascular Biology 11:5, pages 1276-1286.
Crossref
Crossref
Bo Risberg, Svenerik Andreasson & Elsa Eriksson. (1991) Disseminated intravascular coagulation. Acta Anaesthesiologica Scandinavica 35, pages 60-71.
Crossref
Crossref
C F ReillyT FujitaJ E HutzelmannE J MayerR J Shebuski. (1991) Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.. Circulation 84:1, pages 287-292.
Crossref
Crossref
K.-H. Zurborn, J. Gram, K. Glander, K. Delbrück, H. Pelzer, H. Loffler & H.D. Bruhn. (2009) Influence of cytostatic treatment on the coagulation system and fibrinolysis in patients with non-Hodgkin's lymphomas and acute leukemias. European Journal of Haematology 47:1, pages 55-59.
Crossref
Crossref
Bengt I. Eriksson, Erik Hultman, Sven Martinell, Elsa Eriksson, Lilian Tengborn & Bo Risberg. (1991) Regional fibrinolysis following total hip replacement. Thrombosis Research 62:5, pages 441-447.
Crossref
Crossref
J. Schneiderman, R. Adar & N. Savion. (1991) Changes in plasmatic tissue-type plasminogen activator and plasminogen activator inhibitor activity during acute arterial occlusion associated with severe ischemia. Thrombosis Research 62:5, pages 401-408.
Crossref
Crossref
E Nordborg, R Andersson, L Tengborn, S Eden & B A Bengtsson. (1991) von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.. Annals of the Rheumatic Diseases 50:5, pages 316-320.
Crossref
Crossref
C.F. Reilly & R.C. McFall. (1991) Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. Journal of Biological Chemistry 266:15, pages 9419-9427.
Crossref
Crossref
Jacob Schneiderman & David J. Loskutoff. (1991) Plasminogen activator inhibitors. Trends in Cardiovascular Medicine 1:3, pages 99-102.
Crossref
Crossref
Bengt I. Eriksson, Elsa Eriksson & Bo Risberg. (1991) Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients. Thrombosis Research 62:1-2, pages 55-64.
Crossref
Crossref
Michael J. Brockmann, Günther Schwendemann & Thomas W. Stief. (1991) Plasminogen activator inhibitor in acute stroke. Molecular and Chemical Neuropathology 14:2, pages 143-150.
Crossref
Crossref
M Pandolfi & A Al-Rushood. (1991) The role of fibrinolytic factors in ischaemia. Eye 5:2, pages 159-169.
Crossref
Crossref
A J Simpson, N A Booth, N R Moore & B Bennett. (1991) Distribution of plasminogen activator inhibitor (PAI-1) in tissues.. Journal of Clinical Pathology 44:2, pages 139-143.
Crossref
Crossref
W. Schramm & M. Spannagl. 1991. Adult Respiratory Distress Syndrome. Adult Respiratory Distress Syndrome
75
87
.
M. Sawdey & D. J. Loskutoff. 1991. Atherosclerosis. Atherosclerosis
187
208
.
David J. Loskutoff. 1991. Vascular Endothelium. Vascular Endothelium
97
107
.
Felicita Andreotti, M.Carla Roncaglioni, David R. Hackett, Mohamed I. Khan, Tessa Regan, Agha W. Haider, Graham J. Davies, Cornelis Kluft & Attilio Maseri. (1990) Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction. Journal of the American College of Cardiology 16:7, pages 1553-1560.
Crossref
Crossref
S. MUNKVAD, J. JESPERSEN, J. GRAM & C. KLUFT. (2009) Interrelationship between coagulant activity and tissue‐type plasminogen activator (t‐PA) system in acute ischaemic heart disease. Possible role of the endothelium. Journal of Internal Medicine 228:4, pages 361-366.
Crossref
Crossref
Kazuyuki Sakata, Chinori Kurata, Takahisa Taguchi, Shingo Suzuki, Akira Kobayashi, Noboru Yamazaki, Andrzej Rydzewski, Yumiko Takada & Akikazu Takada. (1990) Clinical significance of plasminogen activator inhibitor activity in patients with exercise-induced ischemia. American Heart Journal 120:4, pages 831-838.
Crossref
Crossref
William D. Haire, Robert P. Lieberman, James Edney, William P. Vaughan, Anne Kessinger, James O. Armitage & Jonathan C. Goldsmith. (1990) Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 66:5, pages 900-908.
Crossref
Crossref
DAVID J. LOSKUTOFF & SCOTT A. CURRIDEN. (1990) The Fibrinolytic System of the Vessel Wall and Its Role in the Control of Thrombosis. Annals of the New York Academy of Sciences 598:1 Atheroscleros, pages 238-247.
Crossref
Crossref
A. John Simpson, Nuala A. Booth, Norma R. Moore & Bruce Bennett. (2008) The platelet and plasma pools of plasminogen activator inhibitor (PAI‐1) vary independently in disease. British Journal of Haematology 75:4, pages 543-548.
Crossref
Crossref
E.J. Johnson, H. Hariman, K.K. Hampton, P.J. Grant, J.A. Davies & C.R.M. Prentice. (1990) Fibrinolysis during major abdominal surgery. Fibrinolysis 4:3, pages 147-151.
Crossref
Crossref
Michael Mayer. (1990) Biochemical and biological aspects of the plasminogen activation system. Clinical Biochemistry 23:3, pages 197-211.
Crossref
Crossref
M.C. Alessi, H.J. Parra, P. Joly, N. Vu-Dac, J.M. Bard, J.C. Fruchart & I. Juhan-Vague. (1990) The increased plasma Lp(a) : B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysis. Clinica Chimica Acta 188:2, pages 119-127.
Crossref
Crossref
J. C. KIRCHHEIMER, H. KOULBL, G. TATRA & B. R. BINDER. (2008) Relationship between plasma levels of components of the fibrinolytic system and acute‐phase reactants in patients with uterine malignancies. European Journal of Clinical Investigation 20:1, pages 79-84.
Crossref
Crossref
P.M. Mannucci, M. Cugno, B. Bottasso, F. Marongiu, M. Maniezzo, M. Vaglini & N. Cascinelli. (1990) Changes in fibrinolysis in patients with localized tumors. European Journal of Cancer and Clinical Oncology 26:2, pages 83-87.
Crossref
Crossref
P.J. Grant, K.K. Hampton, J.A. Davies, M. Mahmoud-Alexandroni, P.J. Gaffney & C.R.M. Prentice. (1990) Activation of the intrinsic fibrinolytic pathway with normal extrinsic responses in a patient undergoing gastric surgery. Fibrinolysis 4:1, pages 41-43.
Crossref
Crossref
F. Andreotti, A.C.W. de Bart, T. Regan, A. Maseri & C. Kluft. (1990) Factors affecting the relation between plasminogen activator inhibitor (PAI) activity and PAI-1 antigen levels in normals and in patients with arterial disease. Fibrinolysis 4, pages 134-135.
Crossref
Crossref
T. Kooistra. (1990) The use of cultured human endothelial cells and hepatocytes as an in vitro model system to study modulation of endogenous fibrinolysis. Fibrinolysis 4, pages 33-39.
Crossref
Crossref
Veronica Agrenius, Joanna Chmielewska, Olle Widström & Margareta Blombäck. (1989) Pleural Fibrinolytic Activity Is Decreased in Inflammation as Demonstrated in Quinacrine Pleurodesis Treatment of Malignant Pleural Effusion. American Review of Respiratory Disease 140:5, pages 1381-1385.
Crossref
Crossref
I.G Sloan & B.G Firkin. (1989) Impaired fibrinolysis in patients with thrombotic or haemostatic defects. Thrombosis Research 55:5, pages 559-567.
Crossref
Crossref
Dominique Arnoux, Brigitte Boutière, Marc Houvenaeghel, Agnes Rousset-Rouvière, Patrice Le Treut & José Sampol. (1989) Intraoperative evolution of coagulation parameters and t-PA/PAI balance in orthotopic liver transplantation. Thrombosis Research 55:3, pages 319-328.
Crossref
Crossref
Maureen G. Conlan, William D. Haire & David A. Burnett. (1989) Prothrombotic abnormalities in inflammatory bowel disease. Digestive Diseases and Sciences 34:7, pages 1089-1093.
Crossref
Crossref
Robert B. FrancisJr.Jr.. (1989) Clinical disorders of fibrinolysis: A critical review. Blut 59:1, pages 1-14.
Crossref
Crossref
Displaying 200 of 225 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list